Table 2.
Resistance to antibiotics of H. pylori isolates in males and females from 2012 to 2015, Algeria.
| Antimicrobial | Resistance (%) (n/total) | Resistance in females (%) (n/total) | Resistance in males (%) (n/total) |
|---|---|---|---|
| AMX | 0 (0/151) | 0 (0/151) | 0 (0/151) |
| CIP | 18.5 (28/151) | 9.93 (15/151) | 8.61 (13/151) |
| CLA | 25.2 (38/151) | 15.89 (24/151) | 9.27 (14/151) |
| MTZ | 67.5 (102/151) | 43.05 (65/151) | 24.50 (37/151) |
| RIF | 0 (0/151) | 0 (0/151) | 0 (0/151) |
| TET | 0 (0/151) | 0 (0/151) | 0 (0/151) |
AMX, amoxicillin; CLA, clarithromycin; CIP, ciprofloxacin; MTZ, metronidazole; RIF, rifampicin; TET, tetracycline.